US Broker Ratings

Definitive Healthcare Corp. (DH) Stock Analysis: Uncovering a 44% Potential Upside Amidst Challenging Metrics

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the Health Information Services sector, offers investors a compelling yet complex narrative. Based in Framingham, Massachusetts, the..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Healthcare Innovator with Strategic Partnerships and Revenue Growth

Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning player in the healthcare sector, operates within the biotechnology industry and has carved out a niche by offering comprehensive..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 96% Potential Upside and Analyst Confidence

Bioventus Inc. (NASDAQ: BVS), a North Carolina-based medical device company, is turning heads in the healthcare sector with a compelling potential upside of 96.08%, according to..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Exploring a 35% Potential Upside in the Biotech Sector

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a biotechnology firm based in Cambridge, Massachusetts, stands out in the healthcare sector with its innovative approach to treating neurodegenerative diseases...

Talkspace, Inc. (TALK) Stock Analysis: A 49% Upside Opportunity in Virtual Behavioral Healthcare

Talkspace, Inc. (NASDAQ: TALK) is making waves in the healthcare sector with its innovative approach to mental health services. As a virtual behavioral healthcare company, Talkspace..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating the Diagnostics Sector with a 10% Upside Potential

For investors eyeing the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) stands out as a key player in the field of molecular diagnostics and precision medicine...

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Uncovering a 26% Upside Potential Amidst Clinical Advances

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its ambitious cancer therapy pipeline and a promising upside..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 73% Potential Upside for Investors

Tilray Brands, Inc. (NASDAQ: TLRY) stands as a prominent player in the healthcare sector, particularly in the niche of specialty and generic drug manufacturing. As a..

AMN Healthcare Services Inc (AMN) Stock Analysis: Evaluating a 20% Upside Potential in a Challenging Market

AMN Healthcare Services Inc (NYSE: AMN) is a notable player in the healthcare sector, particularly within the medical care facilities industry. Based in Dallas, Texas, AMN..

Mind Medicine (MNMD) Stock Analysis: Assessing a 111.87% Potential Upside in the Biotech Space

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a trailblazer in the biopharmaceutical sector, is making waves among investors with its innovative approach to treating brain health disorders...

Precigen, Inc. (PGEN) Stock Analysis: A Biotech with 127% Potential Upside

Precigen, Inc. (NASDAQ: PGEN) is capturing investor attention with its impressive potential upside of 127.27%, as suggested by current analyst ratings. As a forward-thinking player in..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges in the Medical Device Sector

Surmodics, Inc. (NASDAQ: SRDX), a key player in the medical devices sector, is currently navigating a complex landscape characterized by challenging financial metrics and a mixed..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 33.6% Upside Potential with Promising Analyst Ratings

Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, is capturing the attention of investors with its compelling growth potential and strategic developments...

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a Unique Growth Story

Sonida Senior Living, Inc. (NASDAQ: SNDA), a prominent player in the healthcare sector specializing in medical care facilities, commands attention from investors seeking exposure to the..

GH Research PLC (GHRS) Stock Analysis: Biotech Firm with Over 100% Potential Upside Attracts Strong Buy Ratings

GH Research PLC (NASDAQ: GHRS) stands out in the healthcare sector as a promising player in the biotechnology industry. Based in Dublin, Ireland, this clinical-stage biopharmaceutical..

Keros Therapeutics, Inc. (KROS) Stock Analysis: A Biotech Gem with a 32.86% Potential Upside

Keros Therapeutics, Inc. (NASDAQ: KROS) stands out in the healthcare sector, particularly within the biotechnology industry, as a promising player with significant growth potential. Focused on..

Weave Communications, Inc. (WEAV) Stock Analysis: Unpacking a 63.53% Potential Upside

Weave Communications, Inc. (NASDAQ: WEAV) has been a notable player within the healthcare sector, specializing in health information services. As of its latest market data, the..

Castle Biosciences, Inc. (CSTL): Analyzing Growth Potential Amidst a Challenging Valuation Landscape

Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the molecular diagnostics sector, has captured investor attention with its cutting-edge diagnostic solutions. Specializing in test solutions..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a 113% Potential Upside in the Biotech Arena

Sana Biotechnology, Inc. (NASDAQ: SANA), a rising star in the biotech sector, is capturing the attention of investors with its ambitious approach to engineered cell medicines...

uniQure N.V. (QURE) Stock Analysis: Assessing the 111% Potential Upside in Biotechnology

Investors with an eye on groundbreaking biotechnological advancements might find uniQure N.V. (NASDAQ: QURE) a compelling opportunity. As a key player in the healthcare sector, uniQure..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds